Live: Thursday 17th October 2024, 18:00-19:30 (CEST)
Frailty has a significant impact on health and wellbeing, especially in older adults. Join our experts to understand the factors that contribute to the development of frailty and find out how to manage the condition and reduce the risk of disability, dependency, and mortality.
In this interactive webinar, a multidisciplinary team of speakers provide practical guidance on managing patients with cutaneous T-cell lymphoma. Learn about the key aspects of diagnosis and treatment via a series of patient cases.
Severe pain is the most common symptom of chronic pancreatitis. In this live webinar, experts shared the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discussed pertinent cases and provided practical suggestions for use within clinical practice.
Watch part 1 of the Expert Hour webinar series on CTCL where Prof. Dr. Maarten Vermeer and Prof. Dr. Rudolf Stadler focus on the challenges of early-stage cutaneous T-cell lymphoma. The experts cover: Basics of CTCL, diagnosis, management and monitoring of mycosis fungoides at an early stage.
Join us for an insightful session tailored for pulmonologists and healthcare professionals eager to enhance their understanding of COPD and the latest advances in biologic therapies.
Listen to our experts discuss their real-world experiences of using biomarkers for practical diagnoses – how best can they be applied? What combination is the most useful for personalised treatment? Discover how our experts are additionally using amyloid-targeting treatments in their clinics.
Dorota Religa and Robert Perneczky walk us through the most exciting findings from the AD/PD™ and CONy 2024 conferences. Their discussion focuses on existing and emerging biomarkers and new amyloid-targeting therapies in Alzheimer's disease.
Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.
Urologist James Catto asks oncologist Thomas Powles key questions on the role of ctDNA in the understanding of urothelial cancer and its potential to improve treatment decision-making in the future.
Next-generation sequencing is a powerful tool that can identify mutations or fusions in a wide range of cancers, enabling physicians to provide targeted therapy to patients and improve outcomes. In this vodcast, Professor Andrew Beggs discusses practical aspects of this technique from the clinical viewpoint.
This content is intended only for healthcare providers, excluding UK.
In this live webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.
Please note, this webinar is not intended for healthcare professionals based in the US and UK.
Dr. Rhian Touyz takes us through the main features of the new ESC guidelines on the management of elevated blood pressure and hypertension, including a new blood pressure category and more ambitious and intensive treatment targets.
Professor Lucia Mazzolai outlines the key recommendations from the new ESC guidelines on peripheral arterial and aortic diseases, such as the importance of screening, emphasis on exercise and lifestyle changes, and optimal pharmacological treatment.
Professor Dipak Kotecha gives an overview of the new ESC guidelines on atrial fibrillation, highlighting the importance of shared decision-making and the new AF-CARE pathway to optimize patient care.
Professor Pardeep Jhund shares the main findings of their meta-analysis of mineralocorticoid receptor antagonists in heart failure, based on data from the RALES, EMPHASIS-HF, TOPCAT, and FINEARTS-HF trials.
Professor Benjamin O'Brien discusses the TIGHT-K study results, which indicate that routine potassium supplementation can be avoided after isolated coronary artery bypass graft surgery.
Professor Johanne Silvain takes us through the main findings of the ABYSS study, which evaluated the safety of beta-blocker interruption versus continuation in people with a history of myocardial infarction.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.